News & Updates

CPX-351, a liposomal encapsulation of cytarabine and daunorubicin, is a promising treatment option for patients with therapy-related acute myeloid leukaemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC), leading to high rates of treatment response and good survival outcomes, a recent study has found.

In Singapore, the number of people assumed to be an organ donor sharply contrasts with the actual number of those willing to donate, and this discrepancy is driven by barriers related to emotions and culture or religion.

Use of a 4-factor prothrombin complex concentrate (4F-PCC) for oral factor Xa (FXa) inhibitor-related acute major bleeding appears to work for most patients, results of a recent study have shown.

It is rare to achieve successful home noninvasive ventilation (NIV) in real life, reports a recent study. To improve patient-centred outcomes, health-related quality of life (HRQOL) and NIV tolerance must then be assessed.